Literature DB >> 25128971

The effects of coronary artery calcium screening on behavioral modification, risk perception, and medication adherence among asymptomatic adults: a systematic review.

Hadii M Mamudu1, Timir K Paul2, Sreenivas P Veeranki3, Matthew Budoff4.   

Abstract

OBJECTIVE: To perform systematic review of the effects of screening for coronary artery calcium (CAC), a subclinical marker of coronary artery disease (CAD), on behavioral or lifestyle modification, risk perception, and medication adherence.
METHODS: We searched through CINAHL, PsychInfo, Web of Science, Cochrane Central Register of Control Trials, and PubMed (Medline) for studies on the effects of CAC screening in asymptomatic individuals across three major domains: behavioral modification, risk perception for CAD, and medication adherence. We extracted data from the retrieved studies, assessed and synthesized the information.
RESULTS: Of the 15 retrieved studies, three were randomized control trials and 12 were observational studies. CAC score was ascertained either as total score, quartiles, or standardized Agatston's ordinal scale. While all the 15 studies involved issues related to behavioral and medication adherence, four involved risk perception of CAD. Although no standardized approach was used in these studies, CAC screening enhanced medication adherence in 13 of the 15 studies, while the others were mixed.
CONCLUSION: CAC screening improved medication adherence and could likely motivated individuals for beneficial behavioral or lifestyle changes to improve CAD. The mixed results suggest the need for further research because screening for subclinical atherosclerosis has significant implications for early detection and prevention of future cardiovascular events by aggressive risk factors modification. Published by Elsevier Ireland Ltd.

Entities:  

Keywords:  Computed tomography; Coronary artery calcium; Coronary artery disease; Lifestyle or behavioral modification; Medication adherence; Risk perception; Screening; Subclinical atherosclerosis; Subclinical markers

Mesh:

Substances:

Year:  2014        PMID: 25128971     DOI: 10.1016/j.atherosclerosis.2014.07.022

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  26 in total

1.  Value-based imaging: Combining coronary artery calcium with myocardial perfusion imaging.

Authors:  Daniel S Berman; Alan Rozanski
Journal:  J Nucl Cardiol       Date:  2016-08-18       Impact factor: 5.952

2.  Statin Trials, Cardiovascular Events, and Coronary Artery Calcification: Implications for a Trial-Based Approach to Statin Therapy in MESA.

Authors:  Martin Bødtker Mortensen; Erling Falk; Dong Li; Khurram Nasir; Michael J Blaha; Veit Sandfort; Carlos Jose Rodriguez; Pamela Ouyang; Matthew Budoff
Journal:  JACC Cardiovasc Imaging       Date:  2017-07-25

Review 3.  The Role of a Coronary Artery Calcium Scan in Type 1 Diabetes.

Authors:  Mark R Burge; R Philip Eaton; David S Schade
Journal:  Diabetes Technol Ther       Date:  2016-09-01       Impact factor: 6.118

Review 4.  Coronary Artery Calcium Scoring in Current Clinical Practice: How to Define Its Value?

Authors:  Sina Kianoush; Mohammadhassan Mirbolouk; Raghavendra Charan Makam; Khurram Nasir; Michael J Blaha
Journal:  Curr Treat Options Cardiovasc Med       Date:  2017-09-25

Review 5.  The early detection of atherosclerosis in type 1 diabetes: why, how and what to do about it.

Authors:  Alicia Jenkins; Andrzej Januszewski; David O'Neal
Journal:  Cardiovasc Endocrinol Metab       Date:  2019-02-13

6.  2016 European Guidelines on cardiovascular disease prevention in clinical practice : The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts).

Authors:  Massimo F Piepoli
Journal:  Int J Behav Med       Date:  2017-06

Review 7.  The Identification of Calcified Coronary Plaque Is Associated With Initiation and Continuation of Pharmacological and Lifestyle Preventive Therapies: A Systematic Review and Meta-Analysis.

Authors:  Ankur Gupta; Emily Lau; Ravi Varshney; Edward A Hulten; Michael Cheezum; Marcio S Bittencourt; Michael J Blaha; Nathan D Wong; Roger S Blumenthal; Matthew J Budoff; Craig A Umscheid; Khurram Nasir; Ron Blankstein
Journal:  JACC Cardiovasc Imaging       Date:  2017-08

8.  The Incremental Diagnostic Performance of Coronary Computed Tomography Angiography Added to Myocardial Perfusion Imaging in Patients with Intermediate-to-High Cardiovascular Risk.

Authors:  Pei-Ying Hsu; Wen-Jeng Lee; Mei-Fang Cheng; Ruoh-Fang Yen; Kai-Yuan Tzen; Yen-Wen Wu
Journal:  Acta Cardiol Sin       Date:  2016-03       Impact factor: 2.672

9.  2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts)Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR).

Authors:  Massimo F Piepoli; Arno W Hoes; Stefan Agewall; Christian Albus; Carlos Brotons; Alberico L Catapano; Marie-Therese Cooney; Ugo Corrà; Bernard Cosyns; Christi Deaton; Ian Graham; Michael Stephen Hall; F D Richard Hobbs; Maja-Lisa Løchen; Herbert Löllgen; Pedro Marques-Vidal; Joep Perk; Eva Prescott; Josep Redon; Dimitrios J Richter; Naveed Sattar; Yvo Smulders; Monica Tiberi; H Bart van der Worp; Ineke van Dis; W M Monique Verschuren; Simone Binno
Journal:  Eur Heart J       Date:  2016-05-23       Impact factor: 29.983

Review 10.  Role of Coronary Calcium Score to Identify Candidates for ASCVD Prevention.

Authors:  Hong Loan Nguyen; Jing Liu; Maygen Del Castillo; Tina Shah
Journal:  Curr Atheroscler Rep       Date:  2019-11-21       Impact factor: 5.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.